Inhaled drug shows promise for rare lung disease combination

A therapeutic principle rooted in decades of pulmonary vascular research is entering a new stage of clinical development. The investigational inhaled drug mosliciguat, a soluble guanylate cyclase (sGC) activator, has produced ...

How damaged mitochondria may contribute to liver disease

Mitochondria supply cells with energy, and they also play an important role in metabolism. The Institute of Biochemistry and Molecular Biology I at Heinrich Heine University Düsseldorf (HHU) and University Hospital Düsseldorf ...

A brainstem signal reorganizes the neural code for taste

Why might food seem appealing in one state of mind and less enticing in another? New UConn research offers insight into how the brain systems that regulate alertness and stress may reshape how taste is represented in the ...

Experimental drug may reduce lymphedema swelling and scarring

Matthew Holbreich was a senior in college when the swelling started. He originally thought he had injured his left leg playing squash, but the intensity of the swelling scared him. After seeing a few doctors in Boston, where ...

page 13 from 40